Skyler Bloom | executive |
Adam Grossman | executive |
Anthony Petrone | analyst |
Kristen Kluska | analyst |
Gary Nachman | analyst |
Good afternoon, and welcome to the ADMA Biologics First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024. [Operator Instructions] Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately 2 hours following the end of the call. At this time, I would like to introduce Skyler Bloom, please go ahead.
Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics' financial results for the first quarter of 2024 and recent corporate updates. I'm joined today by Adam Grossman, President, Chief Executive Officer and Interim Financial Officer; and Brad Tate, Vice President of Financial Operations.